78 trials changed in the last 30 days: 5 stopped, 53 with notable changes, 20 with minor changes only.
Trial terminated
Also in this update: Final enrollment: 36 participants (planned 50); Primary completion date changed from estimate of Oct 31, 2030 to Oct 12, 2026
M.D. Anderson Cancer CenterPhase 2 NCT04062266 Registry history of NCT04062266 on ClinicalTrials.gov (opens the registry)
Trial status changed: Not Yet Recruiting → Suspended
M.D. Anderson Cancer CenterPhase 2 NCT07192237 Registry history of NCT07192237 on ClinicalTrials.gov (opens the registry)
Recruitment suspended
M.D. Anderson Cancer CenterPhase 1/2 NCT05663710 Registry history of NCT05663710 on ClinicalTrials.gov (opens the registry)
Recruitment suspended
M.D. Anderson Cancer CenterPhase 1 NCT06959537 Registry history of NCT06959537 on ClinicalTrials.gov (opens the registry)
Trial terminated
Also in this update: Primary completion date changed from estimate of Mar 30, 2028 to Sep 17, 2026
M.D. Anderson Cancer CenterNot applicable NCT06015295 Registry history of NCT06015295 on ClinicalTrials.gov (opens the registry)
Primary and study completion pushed from Oct 1, 2026 to Oct 1, 2028
M.D. Anderson Cancer CenterPhase 2 NCT06284564 Registry history of NCT06284564 on ClinicalTrials.gov (opens the registry)
Primary and study completion pushed from Aug 31, 2026 to Aug 31, 2028
M.D. Anderson Cancer CenterPhase 2 NCT00761618 Registry history of NCT00761618 on ClinicalTrials.gov (opens the registry)
Primary and study completion pushed from May 31, 2026 to May 31, 2028
M.D. Anderson Cancer CenterEarly Phase 1 NCT02790853 Registry history of NCT02790853 on ClinicalTrials.gov (opens the registry)
Primary and study completion pushed from Jun 1, 2026 to Jan 15, 2027
M.D. Anderson Cancer CenterEarly Phase 1 NCT03059940 Registry history of NCT03059940 on ClinicalTrials.gov (opens the registry)
Primary and study completion pushed from Aug 30, 2026 to Aug 30, 2028
M.D. Anderson Cancer CenterPhase 1 NCT03162627 Registry history of NCT03162627 on ClinicalTrials.gov (opens the registry)
Primary and study completion pushed from Jun 30, 2026 to Dec 31, 2026
M.D. Anderson Cancer CenterNot specified NCT04129138 Registry history of NCT04129138 on ClinicalTrials.gov (opens the registry)
Primary and study completion pushed from May 31, 2026 to May 31, 2028
M.D. Anderson Cancer CenterPhase 2 NCT05044468 Registry history of NCT05044468 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Aug 31, 2026 to Aug 31, 2028
M.D. Anderson Cancer CenterNot specified NCT06722846 Registry history of NCT06722846 on ClinicalTrials.gov (opens the registry)
Primary and study completion pushed from Oct 30, 2026 to Oct 30, 2028
M.D. Anderson Cancer CenterPhase 2 NCT04675710 Registry history of NCT04675710 on ClinicalTrials.gov (opens the registry)
Primary and study completion pushed from Oct 31, 2026 to Oct 31, 2028
M.D. Anderson Cancer CenterPhase 2 NCT00501826 Registry history of NCT00501826 on ClinicalTrials.gov (opens the registry)
Primary and study completion pushed from Aug 31, 2027 to Dec 31, 2029
M.D. Anderson Cancer CenterPhase 3 NCT06851507 Registry history of NCT06851507 on ClinicalTrials.gov (opens the registry)
Primary and study completion pushed from Oct 11, 2026 to Oct 11, 2028
M.D. Anderson Cancer CenterPhase 2 NCT03821792 Registry history of NCT03821792 on ClinicalTrials.gov (opens the registry)
Primary and study completion pushed from Apr 30, 2026 to Apr 30, 2028
M.D. Anderson Cancer CenterPhase 1 NCT01187199 Registry history of NCT01187199 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Nov 1, 2026 to Nov 1, 2028
M.D. Anderson Cancer CenterPhase 2 NCT06053658 Registry history of NCT06053658 on ClinicalTrials.gov (opens the registry)
Primary and study completion pushed from Oct 31, 2026 to Oct 31, 2028
M.D. Anderson Cancer CenterPhase 2 NCT04746235 Registry history of NCT04746235 on ClinicalTrials.gov (opens the registry)
Enrollment closed, study ongoing
M.D. Anderson Cancer CenterPhase 2 NCT03398161 Registry history of NCT03398161 on ClinicalTrials.gov (opens the registry)
Trial status changed: Enrolling by Invitation → Active, Not Recruiting
Also in this update: Final enrollment: 119 participants (planned 300)
M.D. Anderson Cancer CenterPhase 1 NCT02600949 Registry history of NCT02600949 on ClinicalTrials.gov (opens the registry)
Enrollment closed, study ongoing
M.D. Anderson Cancer CenterNot applicable NCT05879159 Registry history of NCT05879159 on ClinicalTrials.gov (opens the registry)
Enrollment closed, study ongoing
M.D. Anderson Cancer CenterNot applicable NCT05053113 Registry history of NCT05053113 on ClinicalTrials.gov (opens the registry)
Enrollment closed, study ongoing
Also in this update: Final enrollment: 30 participants (planned 60)
M.D. Anderson Cancer CenterNot applicable NCT04678427 Registry history of NCT04678427 on ClinicalTrials.gov (opens the registry)
Enrollment closed, study ongoing
Also in this update: Final enrollment: 169 participants (planned 188)
M.D. Anderson Cancer CenterPhase 2/3 NCT05474846 Registry history of NCT05474846 on ClinicalTrials.gov (opens the registry)
Enrollment closed, study ongoing
Also in this update: Final enrollment: 96 participants (planned 200)
M.D. Anderson Cancer CenterPhase 3 NCT01696734 Registry history of NCT01696734 on ClinicalTrials.gov (opens the registry)
Trial completed
Also in this update: Primary completion date changed from estimate of Sep 30, 2026 to Apr 14, 2026
M.D. Anderson Cancer CenterPhase 1 NCT00479128 Registry history of NCT00479128 on ClinicalTrials.gov (opens the registry)
Enrollment closed, study ongoing
M.D. Anderson Cancer CenterPhase 2 NCT05336383 Registry history of NCT05336383 on ClinicalTrials.gov (opens the registry)
Enrollment closed, study ongoing
M.D. Anderson Cancer CenterPhase 1/2 NCT05394337 Registry history of NCT05394337 on ClinicalTrials.gov (opens the registry)
Enrollment closed, study ongoing
Also in this update: Final enrollment: 88 participants (planned 119)
M.D. Anderson Cancer CenterPhase 2 NCT04870762 Registry history of NCT04870762 on ClinicalTrials.gov (opens the registry)
Enrollment closed, study ongoing
Also in this update: Final enrollment: 30 participants (planned 25)
M.D. Anderson Cancer CenterPhase 2 NCT05343013 Registry history of NCT05343013 on ClinicalTrials.gov (opens the registry)
Trial completed
Also in this update: Primary completion date changed from estimate of Dec 31, 2027 to Sep 22, 2026
M.D. Anderson Cancer CenterPhase 1 NCT05273554 Registry history of NCT05273554 on ClinicalTrials.gov (opens the registry)
Enrollment closed, study ongoing
M.D. Anderson Cancer CenterPhase 1 NCT06308419 Registry history of NCT06308419 on ClinicalTrials.gov (opens the registry)
Enrollment increased: 52 → 72 participants
M.D. Anderson Cancer CenterPhase 2 NCT03629171 Registry history of NCT03629171 on ClinicalTrials.gov (opens the registry)
Enrollment increased: 55 → 65 participants
M.D. Anderson Cancer CenterPhase 1 NCT05335811 Registry history of NCT05335811 on ClinicalTrials.gov (opens the registry)
Enrollment increased: 45 → 54 participants
M.D. Anderson Cancer CenterNot applicable NCT06840262 Registry history of NCT06840262 on ClinicalTrials.gov (opens the registry)
Study completion pushed from Aug 3, 2026 to Aug 3, 2028
M.D. Anderson Cancer CenterPhase 3 NCT04810091 Registry history of NCT04810091 on ClinicalTrials.gov (opens the registry)
Study completion pushed from Oct 31, 2026 to Oct 31, 2027
M.D. Anderson Cancer CenterPhase 2 NCT04083378 Registry history of NCT04083378 on ClinicalTrials.gov (opens the registry)
Start date moved earlier from Mar 1, 2027 to Dec 1, 2026
M.D. Anderson Cancer CenterNot applicable NCT07852858 Registry history of NCT07852858 on ClinicalTrials.gov (opens the registry)
| First posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-10-16 | NCT07877220 Estimating The Rate Of Complete Ablation (A0) With The Use Of Biomechanical Deformable… | Not Yet Recruiting | |
| 2026-10-15 | NCT07874828 PROACT AYA: Preventing Overweight/Obesity-Associated Cardiotoxicity With Tirzepatide In… | Phase 2 | Not Yet Recruiting |
| 2026-10-13 | NCT07871760 Long-Term Quality Of Life And Symptom Assessment Among Recurrence-Free Patients Who… | Not Yet Recruiting | |
| 2026-10-13 | NCT07871773 Food Is Medicine In Survivorship (Foodiis-AYA): Examining The Feasibility And… | Not Yet Recruiting | |
| 2026-10-05 | NCT07856719 A Ph2, Colchicine For Inflammatory Carotid Injury And Disease Evolution After Radiotherapy | Phase 2 | Not Yet Recruiting |
| 2026-10-05 | NCT07856758 2 Gy Total Body Irradiation As Part Of Conditioning Treatment For Patients With Acute… | Not Yet Recruiting | |
| 2026-10-05 | NCT07859514 Prospective Study To Assess The Outcomes Of Nitrous Oxide Cryoablation For Treatment Of… | Not Yet Recruiting | |
| 2026-10-02 | NCT07855627 Prediction Of Lymphedema In Patients With Inflammatory BreastCancer Using Preoperative… | Recruiting | |
| 2026-10-01 | NCT07850973 Phase 1/2 Study Of PARP Inhibition With Olaparib To Enhance The Efficacy Of High-Dose… | Phase 1/2 | Not Yet Recruiting |
| 2026-10-01 | NCT07852858 Supporting Families In Coping With Parental Cancer: A Multi-Site Randomized Controlled… | Not Yet Recruiting |
| Early Phase 1 | 27 | |
| Phase 1 | 132 | |
| Phase 1/2 | 93 | |
| Phase 2 | 349 | |
| Phase 2/3 | 12 | |
| Phase 3 | 25 | |
| Phase 4 | 8 |
Leukemia (121) · Breast Cancer (97) · Head & Neck Cancer (74) · Lung Cancer (64) · Acute Myeloid Leukemia (AML) (57) · Colorectal Cancer (51) · Non-Hodgkin Lymphoma (46) · Melanoma (44) · Prostate Cancer (43) · Sarcoma (43)